On the morning of the 21st, the KOSPI and the won-dollar exchange rate are displayed on the screen of the dealing room at Hana Bank headquarters in Jung-gu, Seoul. On this day, the KOSPI is rising nearly 1% during trading. /Courtesy of Yonhap News Agency

The Korea Composite Stock Price Index (KOSPI) is rising by nearly 1% during the session, thanks to the simultaneous buying by institutions and foreigners.

According to the Korea Exchange on the 21st, as of 10:45 a.m., the KOSPI index recorded 2,627.25, up 25.45 points (0.98%) compared to the previous transaction day.

The index started at 2,615.90, up 14.10 points (0.54%) from the previous session, and thanks to the simultaneous buying by institutions and foreigners, it also surpassed the 2,630 level.

In the market transaction trend of the KOSPI, institutions are net buying 121.7 billion won. Foreigners are also net buying 87.7 billion won. Individuals are net selling 221.7 billion won.

Large-cap stocks on the KOSPI all rose, driving the index higher. Among the top 30 stocks in the KOSPI by market capitalization, 26 stocks are up.

Samsung Electronics, the top stock on the KOSPI, is up 0.72%, while Samsung Biologics is showing a strong increase of over 4%. LG Energy Solution, Hanwha Aerospace, and others are also doing well.

As of 10:45 a.m. that day, the decline in stock prices was limited to four stocks: SK hynix, Hyundai Mobis, Korea Electric Power Corporation, and Samsung Fire & Marine Insurance.

At the same time, the KOSDAQ index showed an increase of 10.88 points (1.52%) to 726.43. The index started at 720.64, up 5.09 points (0.71%) from the previous session, and expanded its gains.

In the KOSDAQ market, institutions and foreigners are both in a buying position. Institutions are net buying 45.8 billion won, while foreigners are net buying 28.9 billion won. Individuals are net selling 66.9 billion won.

By stock, secondary battery stocks such as Ecopro and ECOPRO BM, along with Alteogen, RAINBOW, and Rainbow Robotics, are experiencing rises among most of the top market-cap stocks.

HUGEL, which reported its highest ever results in the first quarter thanks to its botulinum toxin "Botulax," has seen its stock price rise more than 6% that day. Entertainment companies like SME and JYP Entertainment are experiencing declines.